Canonical and Alternative Pathways (Insulin and Exercise) of GLUT4 Synthesis, Signaling, Intracellular Clustering, and Recruitment to the Plasma Membrane

Glucose transporter type 4 (GLUT4), encoded by the SLC2A4 gene, is the final effector of insulin-stimulated glucose uptake in insulin-sensitive tissues: skeletal muscle, adipose tissue, and cardiac muscle. Its dynamic localization, retained intracellularly under basal conditions and massively translocated to the plasma membrane upon stimulation, makes it a master regulator of glycemic homeostasis. While the canonical insulin pathway (PI3K/Akt/TBC1D4) is the most potent and specific mechanism, its dysfunction is associated with insulin resistance and type 2 diabetes. Crucially, there are robust signaling pathways that are completely independent of insulin and regulate GLUT4 synthesis and translocation. Among these, those activated by muscle contraction are prominent, employing calcium signals (via CaMKII), mechanical/metabolic stress (via p38 MAPK γ/δ), and AMP-activated protein kinase (AMPK) activation. This review critically and comprehensively integrates current knowledge, from the molecular architecture of GLUT4 and its facilitated transport mechanism to the complex signaling networks converging on its regulation. The hierarchy, redundancy, and interdependence of these pathways are emphasized. It discusses how understanding insulin-independent mechanisms offers promising therapeutic opportunities for metabolic diseases, particularly for mimicking the benefits of exercise. Finally, future research directions are proposed to translate this molecular knowledge into novel clinical interventions.